- Home
- VHC vs KAPA Comparison
VHC vs KAPA Comparison
Compare VHC & KAPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHC
- KAPA
- Stock Information
- Founded
- VHC 2005
- KAPA 2013
- Country
- VHC United States
- KAPA United States
- Employees
- VHC N/A
- KAPA N/A
- Industry
- VHC Multi-Sector Companies
- KAPA
- Sector
- VHC Miscellaneous
- KAPA
- Exchange
- VHC Nasdaq
- KAPA NYSE
- Market Cap
- VHC 26.2M
- KAPA 21.3M
- IPO Year
- VHC 1999
- KAPA 2024
- Fundamental
- Price
- VHC $5.85
- KAPA $1.56
- Analyst Decision
- VHC
- KAPA Strong Buy
- Analyst Count
- VHC 0
- KAPA 1
- Target Price
- VHC N/A
- KAPA $9.00
- AVG Volume (30 Days)
- VHC 6.0K
- KAPA 698.3K
- Earning Date
- VHC 11-13-2024
- KAPA 11-23-2024
- Dividend Yield
- VHC N/A
- KAPA N/A
- EPS Growth
- VHC N/A
- KAPA N/A
- EPS
- VHC N/A
- KAPA N/A
- Revenue
- VHC $5,000.00
- KAPA N/A
- Revenue This Year
- VHC N/A
- KAPA N/A
- Revenue Next Year
- VHC N/A
- KAPA N/A
- P/E Ratio
- VHC N/A
- KAPA N/A
- Revenue Growth
- VHC N/A
- KAPA N/A
- 52 Week Low
- VHC $3.55
- KAPA $1.22
- 52 Week High
- VHC $9.44
- KAPA $4.00
- Technical
- Relative Strength Index (RSI)
- VHC 30.31
- KAPA N/A
- Support Level
- VHC $5.87
- KAPA N/A
- Resistance Level
- VHC $6.08
- KAPA N/A
- Average True Range (ATR)
- VHC 0.21
- KAPA 0.00
- MACD
- VHC -0.01
- KAPA 0.00
- Stochastic Oscillator
- VHC 13.70
- KAPA 0.00
About VHC VirnetX Holding Corp
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services, and critical infrastructures.
About KAPA KAIROS PHARMA LTD
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.